Anti-Cripto1/CRIPTO antibody [EPR22230-60]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal Cripto1/CRIPTO antibody. Suitable for IP, WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
CRIPTO-1, TDGF1, CRIPTO, Protein Cripto, Cripto-1 growth factor, Epidermal growth factor-like cripto protein CR1, Teratocarcinoma-derived growth factor 1, CRGF
- IP
Supplier Data
Immunoprecipitation - Anti-Cripto1/CRIPTO antibody [EPR22230-60] (AB229016)
Cripto1/CRIPTO was immunoprecipitated from 0.35 mg of NCCIT (human pluripotent embryonic carcinoma cell line) whole cell lysate with ab229016 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab229016 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.
Lane 1 : NCCIT whole cell lysate 10 μg (Input).
Lane 2 : ab229016 IP in NCCIT whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab229016 in NCCIT whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 2 minutes.
All lanes:
Immunoprecipitation - Anti-Cripto1/CRIPTO antibody [EPR22230-60] (ab229016)
Predicted band size: 21 kDa
false
- WB
Supplier Data
Western blot - Anti-Cripto1/CRIPTO antibody [EPR22230-60] (AB229016)
Blocking/Dilution buffer : 5% NFDM/TBST.
The double bands observed are consistent with what has been described in the literature. The lower band represents the immature form of Cripto1/CRIPTO. The upper band is likely to be the processed glycosylated form (PMID : 27881714 and 20568225).
All lanes:
Western blot - Anti-Cripto1/CRIPTO antibody [EPR22230-60] (ab229016) at 1/1000 dilution
All lanes:
NCCIT (human pluripotent embryonic carcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 21 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
The Journal of biological chemistry 300:107783 PubMed39303913
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com